Valuations still count consider WAG $ 40 and PS of .50 to
I'm looking for a sustainable trend RAD $ 1.38 is the way. Just off multi yr. loses and lows in stock price then beating the street and raising guidance. The flu shots are being sold out and this trend has just started and other support products are having the same demands. RAD is a gold mind and is working on refinancing a private equity group or insurance group or hospital group would do well to get RAD RAD is a great way to play on the new insurance rules. Rad valuations are just to compelling and a very big part to health care in the future front line demand. RAD is price at 1/10 it's peers WAG CVS they won't double in stock price but RAD will.
Check the charts, check the analyst upgrades, look at the increased volume and the money flow.